Cargando…
Correction: Kao et al. RNF8–CDH1 Co-Expression Predicts Clinical Benefit of Chemoradiotherapy in Triple-Negative Breast Cancer. J. Pers. Med. 2021, 11, 655
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8953598/ https://www.ncbi.nlm.nih.gov/pubmed/35330508 http://dx.doi.org/10.3390/jpm12030466 |
| _version_ | 1784675890699960320 |
|---|---|
| author | Kao, Chieh-Ni Moi, Sin-Hua Hou, Ming-Feng Luo, Chi-Wen Chen, Fang-Ming Pan, Mei-Ren |
| author_facet | Kao, Chieh-Ni Moi, Sin-Hua Hou, Ming-Feng Luo, Chi-Wen Chen, Fang-Ming Pan, Mei-Ren |
| author_sort | Kao, Chieh-Ni |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8953598 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | MDPI |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-89535982022-03-26 Correction: Kao et al. RNF8–CDH1 Co-Expression Predicts Clinical Benefit of Chemoradiotherapy in Triple-Negative Breast Cancer. J. Pers. Med. 2021, 11, 655 Kao, Chieh-Ni Moi, Sin-Hua Hou, Ming-Feng Luo, Chi-Wen Chen, Fang-Ming Pan, Mei-Ren J Pers Med Correction MDPI 2022-03-15 /pmc/articles/PMC8953598/ /pubmed/35330508 http://dx.doi.org/10.3390/jpm12030466 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
| spellingShingle | Correction Kao, Chieh-Ni Moi, Sin-Hua Hou, Ming-Feng Luo, Chi-Wen Chen, Fang-Ming Pan, Mei-Ren Correction: Kao et al. RNF8–CDH1 Co-Expression Predicts Clinical Benefit of Chemoradiotherapy in Triple-Negative Breast Cancer. J. Pers. Med. 2021, 11, 655 |
| title | Correction: Kao et al. RNF8–CDH1 Co-Expression Predicts Clinical Benefit of Chemoradiotherapy in Triple-Negative Breast Cancer. J. Pers. Med. 2021, 11, 655 |
| title_full | Correction: Kao et al. RNF8–CDH1 Co-Expression Predicts Clinical Benefit of Chemoradiotherapy in Triple-Negative Breast Cancer. J. Pers. Med. 2021, 11, 655 |
| title_fullStr | Correction: Kao et al. RNF8–CDH1 Co-Expression Predicts Clinical Benefit of Chemoradiotherapy in Triple-Negative Breast Cancer. J. Pers. Med. 2021, 11, 655 |
| title_full_unstemmed | Correction: Kao et al. RNF8–CDH1 Co-Expression Predicts Clinical Benefit of Chemoradiotherapy in Triple-Negative Breast Cancer. J. Pers. Med. 2021, 11, 655 |
| title_short | Correction: Kao et al. RNF8–CDH1 Co-Expression Predicts Clinical Benefit of Chemoradiotherapy in Triple-Negative Breast Cancer. J. Pers. Med. 2021, 11, 655 |
| title_sort | correction: kao et al. rnf8–cdh1 co-expression predicts clinical benefit of chemoradiotherapy in triple-negative breast cancer. j. pers. med. 2021, 11, 655 |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8953598/ https://www.ncbi.nlm.nih.gov/pubmed/35330508 http://dx.doi.org/10.3390/jpm12030466 |
| work_keys_str_mv | AT kaochiehni correctionkaoetalrnf8cdh1coexpressionpredictsclinicalbenefitofchemoradiotherapyintriplenegativebreastcancerjpersmed202111655 AT moisinhua correctionkaoetalrnf8cdh1coexpressionpredictsclinicalbenefitofchemoradiotherapyintriplenegativebreastcancerjpersmed202111655 AT houmingfeng correctionkaoetalrnf8cdh1coexpressionpredictsclinicalbenefitofchemoradiotherapyintriplenegativebreastcancerjpersmed202111655 AT luochiwen correctionkaoetalrnf8cdh1coexpressionpredictsclinicalbenefitofchemoradiotherapyintriplenegativebreastcancerjpersmed202111655 AT chenfangming correctionkaoetalrnf8cdh1coexpressionpredictsclinicalbenefitofchemoradiotherapyintriplenegativebreastcancerjpersmed202111655 AT panmeiren correctionkaoetalrnf8cdh1coexpressionpredictsclinicalbenefitofchemoradiotherapyintriplenegativebreastcancerjpersmed202111655 |